Unique ID issued by UMIN | UMIN000057849 |
---|---|
Receipt number | R000066028 |
Scientific Title | Feasibility of the "Clip with Line Pulley Securing (CLiPS)" Technique for Closure After Colorectal ESD: A Prospective Study |
Date of disclosure of the study information | 2025/05/13 |
Last modified on | 2025/05/13 08:26:48 |
Feasibility of the "Clip with Line Pulley Securing (CLiPS)" Technique for Closure After Colorectal ESD: A Prospective Study
C-CLiPS Study
Feasibility of the "Clip with Line Pulley Securing (CLiPS)" Technique for Closure After Colorectal ESD: A Prospective Study
C-CLiPS Study
Japan |
Colorectal Tumor
Gastroenterology |
Malignancy
NO
To evaluate the effectiveness and safety of the CLiPS technique for post colorectal ESD defect closure.
Safety,Efficacy
Complete Closure rate
1. Evaluation of the Closure Technique (Time required for defect closure,Types and number of devices used, Procedure-related adverse events)
2. Incidence of Post-closure Adverse Events (Delayed bleeding, Delayed perforation, Other complications)
3. Closure Integrity (Maintenance of defect closure at 2 days post-procedure)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Maneuver |
Post-colorectal ESD defects is approximated by the CLiPS technique, which involves pulling the mucosa together with a clip-line and securing with an endoloop.
20 | years-old | <= |
Not applicable |
Male and Female
Inclusion Criteria
Age over 20 years at registration.
ECOG Performance Status of 0 or 1.
Lesion size between 20-50 mm.
The most recent blood test within 30 days prior to registration meets all of the following criteria (no blood transfusion within 14 days prior to the test used for registration)
Hemoglobin over 9 g/dL
Platelet count above 100,000
AST/ALT below 100
Serum creatinine below 2.0 mg/dL
Able to be followed for 28 days after treatment.
Written informed consent has been obtained.
Exclusion Criteria
History of endoscopic treatment for lower gastrointestinal lesions within 28 days prior to enrollment.
Planned endoscopic treatment for the lower gastrointestinal tract within 28 days after the procedure.
Planned treatment of multiple lesions at the same time.
Presence of active inflammatory bowel disease (ulcerative colitis or Crohn's disease).
History of radiation therapy to the planned ESD area.
Women who are possibly pregnant, currently pregnant, or breastfeeding.
Presence of psychiatric conditions that impair understanding of the study.
History of myocardial infarction or unstable angina within the past 3 months.
Presence of a coagulation disorder (regardless of antithrombotic medication use).
Active bacterial or fungal infection (defined as fever over 38.5 degrees with supporting radiologic or microbiological evidence).
Presence of respiratory disease requiring continuous oxygen therapy.
Uncontrolled hypertension.
Any other condition deemed inappropriate for study participation by the investigator.
50
1st name | Hiroshi |
Middle name | |
Last name | Yamazaki |
NTT Medical Center Tokyo
Gastrointestinal Endoscopy
141-0022
5-9-22Higashi Gotanda, Shinagawa, Tokyo
03-3448-6111
hiroyama90@hotmail.com
1st name | Hiroshi |
Middle name | |
Last name | Yamazaki |
NTT Medical Center Tokyo
Gastrointestinal Endoscopy
141-0022
5-9-22Higashi Gotanda, Shinagawa, Tokyo
03-3448-6111
hiroyama90@hotmail.com
NTT Medical Center Tokyo
Hiroshi Yamazaki
self funding
Self funding
NTT Medical Center Tokyo
5-9-22Higashi Gotanda, Shinagawa, Tokyo
03-3448-6111
hiroyama90@hotmail.com
NO
Tokyo
2025 | Year | 05 | Month | 13 | Day |
Unpublished
Preinitiation
2025 | Year | 05 | Month | 12 | Day |
2025 | Year | 05 | Month | 15 | Day |
2026 | Year | 05 | Month | 15 | Day |
2025 | Year | 05 | Month | 13 | Day |
2025 | Year | 05 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066028